AzTrials
AzTrials

Decision Support Systems, ClinicalPhase 1/2EBMeDSNCT00915304

Evidence-Based Medicine Electronic Decision Support Study

A Phase 1/2 study testing The EBMeDS reminders in people with Decision Support Systems, Clinical, run by Tampere University at 1 site in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to analyze the effect of the Evidence-Based Medicine electronic Decision Support (EBMeDS) automatic reminders in primary health care. Hypothesis (1)is that in the intervention group the total number of EBMeDS reminders will decrease compared to the control group. Read more about this study

Who is it for?
Any age
Conditions the study is for
Decision Support Systems, Clinical
What is being tested?
The EBMeDS reminders
How many people
12,101 participants
Where
1 siteFinland
Study dates
Jun 2009to Feb 2011
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • All residents of Sipoo who have patient ID number in the Mediatri electronic patient record system in Sipoo Health Centre

Who cannot join

  • Those residents who's occupational health care is produced by Sipoo Health Centre

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • University of Tampere; School of Health Sciences

    Tampere, Finland, 33014

Other trials in Finland

About this study

Official title: Patient Specific Automatic Reminders in Primary Care - the EBMeDS Randomised Trial

The purpose of this study is to analyze the effect of the Evidence-Based Medicine electronic Decision Support (EBMeDS) automatic reminders in primary health care.

Hypothesis (1)is that in the intervention group the total number of EBMeDS reminders will decrease compared to the control group.

Hypothesis (2) is that in the intervention group the quality measures will increase faster compared to the control group at follow-up time.

Being tested
The EBMeDS reminders
Keywords
Clinical Decision Support System, Automatic reminder, Primary care, Evidence-Based Medicine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The EBMeDS remindersBehavioural

    Phase I: EBMeDS reminders specific to the visiting or caring patient and his/her clinical problem are generated when the practitioner uses the electronic patient record. During visits of intervention group patients the EBMeDS reminders will be shown on screen to the practitioner.

    Phase II: As phase I and in addition, results of the Virtual Health Check (VHC) of all the intervention group patients will be shown to the practitioners.Phase II will be fulfilled in Autumn 2010 and follow-up time will be about 3 months.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of reminders triggered (in relation to the number of eligible patients, Ri/Ni) during repeated Virtual Health Checks (VHCs)

    VHC will be performed once a week for the whole study population, beginning at baseline and before randomisation. The main outcome measure is Ri/Ni at follow-up time after commencement of the study where Ri is the total number of reminders triggered by the patient record data in intervention and in control group at the time of analysis, and Ni is the total number of patients.

    Measured: Follow-up time max one and half year

Secondary outcomes (1)
  1. Specific clinical measures compared to an intervention and a control group

    Clinical measures as mean values of laboratory parameters, for example a mean level of HbA1c, a mean level of total cholesterol.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2009 (estimated)
  2. Study startJun 2009
  3. Primary completionFeb 2011
  4. Study completionFeb 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Single group
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
12,101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00915304
Sponsor's protocol ID
EBMeDS-40344-06
Acronym
EBMeDS
Status last verified
Dec 2012
First submitted
5 Jun 2009
Last updated
18 Dec 2012
Results posted
No
Data monitoring committee
No

Publications

  • Kortteisto T, Raitanen J, Komulainen J, Kunnamo I, Makela M, Rissanen P, Kaila M; EBMeDS (Evidence-Based Medicine electronic Decision Support) Study Group. Patient-specific computer-based decision support in primary healthcare--a randomized trial. Implement Sci. 2014 Jan 20;9:15. doi: 10.1186/1748-5908-9-15.

    PubMed 24444113

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing The EBMeDS reminders in people with Decision Support Systems, Clinical, run by Tampere University at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Dec 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of reminders triggered (in relation to the number of eligible patients, Ri/Ni) during repeated Virtual Health Checks (VHCs) (time frame: Follow-up time max one and half year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00915304, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in